$250 | Single User
$500 | Site License
$750 | Global License

Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
[Lowest Price Guaranteed: $250]

Published by Global Data: 23 Oct 2018 | 226394 | In Stock
Related Topics: Business , Equity , Financial , Healthcare , Pharmaceuticals

Introduction

Summary

Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, antitumor medication, respiratory medication, and musculoskeletal disorders. Its pipeline products include ropivacaine mesylate for injection; and irritable bowel syndrome with constipation in women, lubiprostone, antihistamine, vitamins and minerals, developed for chronic idiopathic constipation, opioid-induced constipation. Harbin Gloria also provides SX-004 for the treatment of acute leukemias and solid tumors. The company also collaborates with hospitals and institutions to carry out its research activities. Harbin Gloria is headquartered in Harbin, China.

Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Harbin Gloria Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

    Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

    Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11

    Partnerships 11

    Genscript Biotech and Harbin Gloria Pharma Enter into Development Agreement 11

    Licensing Agreements 12

    Arcus Biosciences Enters into Licensing Agreement with Wuxi Biologics and Harbin Gloria Pharma for GLS-010 12

    Equity Offering 13

    Harbin Gloria Pharma Raises USD3.7 Million in Private Placement of Shares 13

    Harbin Gloria Pharma Completes Spin-Off of Two Subsidiaries 14

    Harbin Gloria Pharma to Raise USD628.7 Million in Private Placement of Shares 15

    Debt Offering 16

    Harbin Gloria Pharma to Raise USD243 Million in Public Offering of Notes Due 2019 16

    Harbin Gloria Pharma Raises USD72.8 Million in Public Offering of 5.1% Notes Due 2020 17

    Acquisition 18

    Harbin Gloria Pharma Acquires Shanghai Huatuo Medical Science For US3.5 Million 18

    Harbin Gloria Pharmaceuticals Co Ltd - Key Competitors 19

    Harbin Gloria Pharmaceuticals Co Ltd - Key Employees 20

    Harbin Gloria Pharmaceuticals Co Ltd - Locations And Subsidiaries 21

    Head Office 21

    Appendix 22

    Methodology 22

    About GlobalData 22

    Contact Us 22

    Disclaimer 22

List Of Tables
in Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Harbin Gloria Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Harbin Gloria Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genscript Biotech and Harbin Gloria Pharma Enter into Development Agreement 11

Arcus Biosciences Enters into Licensing Agreement with Wuxi Biologics and Harbin Gloria Pharma for GLS-010 12

Harbin Gloria Pharma Raises USD3.7 Million in Private Placement of Shares 13

Harbin Gloria Pharma Completes Spin-Off of Two Subsidiaries 14

Harbin Gloria Pharma to Raise USD628.7 Million in Private Placement of Shares 15

Harbin Gloria Pharma to Raise USD243 Million in Public Offering of Notes Due 2019 16

Harbin Gloria Pharma Raises USD72.8 Million in Public Offering of 5.1% Notes Due 2020 17

Harbin Gloria Pharma Acquires Shanghai Huatuo Medical Science For US3.5 Million 18

Harbin Gloria Pharmaceuticals Co Ltd, Key Competitors 19

Harbin Gloria Pharmaceuticals Co Ltd, Key Employees 20

List Of Figures, Charts and Diagrams
in Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Harbin Gloria Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

226394 | GDPH3242364D

Number of Pages

22

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produce...
12 Mar 2018 by Global Data USD $250 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produce...
28 Nov 2017 by Global Data USD $250 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Financial and Strategic SWOT Analysis Review
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produce...
13 Nov 2017 by Global Data USD $300 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company th...
28 Aug 2017 by Global Data USD $250 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Financial and Strategic SWOT Analysis Review
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company th...
07 Aug 2017 by Global Data USD $300 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Financial and Strategic SWOT Analysis Review
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company th...
15 May 2017 by Global Data USD $300 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company th...
25 Apr 2017 by Global Data USD $250 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company th...
23 Mar 2017 by Global Data USD $250 More Info
Harbin Gloria Pharmaceuticals Co Ltd (002437) - Financial and Strategic SWOT Analysis Review
SummaryHarbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company th...
13 Jan 2017 by Global Data USD $300 More Info
Harbin Pharmaceutical Group Holding Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Review
Harbin Pharmaceutical Group Holding Co., Ltd. (600664) - Financial and Strategic SWOT Analysis Revie...
19 Apr 2016 by Global Data USD $125 More Info

This report is published by Global Data

Download Free Report Summary PDF

Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...